Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Noradrenergic basis of Parkinson's tremor fMRI study
NL-OMON55729Phase 4Active, not recruiting
- Sponsor
- Neurologie
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of propranolol in Parkinson's disease (PD), sponsored by Neurologie. Started Oct 2019; status: active, not recruiting.
02
Drugs
propranolol
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NL-OMON55729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55729.